Ly-49L Activators
Ly-49L activators encompass a range of chemical compounds that indirectly enhance the functional activity of Ly-49L, predominantly through modulation of natural killer (NK) cell signaling pathways. Compounds like Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8), which activate protein kinase C (PKC), indirectly bolster Ly-49L activity by enhancing NK cell activation and cytotoxic capabilities. Similarly, Ionomycin, by increasing intracellular calcium levels, and Interleukin-2 (IL-2) and Interleukin-15 (IL-15), through their pivotal roles in NK cell proliferation and activation, contribute to the upregulation of Ly-49L functionality. Additionally, Bisindolylmaleimide I, though a PKC inhibitor, and U0126, a MEK inhibitor, impact Ly-49L indirectly by altering NK cell signaling dynamics, indicating the intricate balance within NK cell pathways that govern Ly-49L activity.
The influence of PI3K inhibitors like Wortmannin and LY294002, along with Rapamycin, an mTOR inhibitor, further exemplifies the complexity of the signaling networks impacting Ly-49L. By modulating crucial pathways like PI3K and mTOR within NK cells, these compounds indirectly affect Ly-49L's role in NK cell-mediated immune responses. Furthermore, SB203580 and Anisomycin, which target the p38 MAPK and JNK pathways respectively, underscore the significant impact of MAPK signaling modulation on Ly-49L activity. Through these diverse yet interconnected pathways, these activators collectively enhance the functional activity of Ly-49L in NK cells, highlighting the sophisticated network of cellular signaling that governs the immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a protein kinase C (PKC) activator. PKC, once activated, can influence the signaling pathways that regulate natural killer (NK) cell functions, enhancing the activity of Ly-49L in NK cells by promoting their activation and cytotoxicity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular calcium levels. Elevated calcium can activate signaling cascades that are crucial for NK cell activation, indirectly enhancing the functional activity of Ly-49L by promoting NK cell responsiveness. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a PKC inhibitor. By selectively inhibiting certain PKC isoforms, it can alter NK cell signaling, leading to an indirect enhancement of Ly-49L activity due to altered cellular signaling dynamics. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is a synthetic diacylglycerol (DAG) analogue and activates PKC. PKC activation can modulate NK cell functions, indirectly enhancing the activity of Ly-49L by promoting NK cell activation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor. By inhibiting MEK, it can impact the MAPK/ERK pathway, a crucial signaling route in NK cells. This modulation can indirectly affect Ly-49L function by altering the cellular context in which it operates. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. Inhibition of the PI3K pathway can affect NK cell activation and function, indirectly influencing Ly-49L activity by altering signaling pathways relevant to NK cell responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and metabolism. In NK cells, mTOR inhibition can alter the functional state, potentially enhancing Ly-49L activity by influencing the cellular environment and activation status. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor. By modulating the p38 MAPK pathway in NK cells, it can indirectly affect Ly-49L activity by altering the signaling environment and influencing NK cell responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is another PI3K inhibitor. By altering PI3K signaling in NK cells, it can indirectly influence Ly-49L activity through changes in cell activation and function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. By activating JNK, it can affect NK cell functions, thereby indirectly influencing Ly-49L activity through altered signaling pathways relevant to NK cell activation and cytotoxicity. | ||||||